Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00412880
Status:
COMPLETED
Last Update Posted:
2022-06-22
First Post:
2006-12-18
Brief Title:
BI 2536 Second Line Monotherapy in SCLC
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Carcinoma Small Cell |
Keywords: